Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atreca Inc Cl A (NQ: BCEL )

1.285 +0.105 (+8.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 182,385
Open 1.240
Bid (Size) 1.230 (3)
Ask (Size) 1.300 (5)
Prev. Close 1.180
Today's Range 1.220 - 1.300
52wk Range 0.7595 - 3.920
Shares Outstanding 38,720,575
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Preview: Atreca's Earnings
 
Via Benzinga
Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023
Call/webcast to feature updates on the discovery platform and pipeline, including updated data from the ongoing Phase 1b trial of ATRC-101 
From Atreca, Inc.
Via Globe NewsWire

Performance

YTD
+40.45%
+40.45%
1 Month
-9.51%
-9.51%
3 Month
+64.70%
+64.70%
6 Month
-16.56%
-16.56%
1 Year
-66.45%
-66.45%

More News

Read More
Atreca to Participate at Cowen’s 43rd Annual Health Care Conference
From Atreca, Inc.
Via Globe NewsWire
Why Is T2 Biosystems (TTOO) Stock Down 21% Today?
Via InvestorPlace
Why Is Atreca (BCEL) Stock Up Today?
Via InvestorPlace
Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target
From Atreca, Inc.
Via Globe NewsWire
Atreca Appoints Philippe Bishop, MD as Chief Medical Officer
From Atreca, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
Atreca Reports Third Quarter 2022 Financial Results and Provides Pipeline Update
From Atreca, Inc.
Via Globe NewsWire
Atreca to Present at Upcoming Investor Conferences
From Atreca, Inc.
Via Globe NewsWire
Atreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting
From Atreca, Inc.
Via Globe NewsWire
IBM And 20 Stocks Moving Premarket
Via Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
Via Benzinga
Tesla, WD-40 Company And 40 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.